Altered FASN activity/expression has been reported in metabolic syndrome and overweight subjects who exhibit obesity, inflammation, hypertension, insulin resistance, dyslipidemia and atherosclerosis, indicating a relationship between FASN and the pathogenesis of hypertension and metabolic dysfunction4, 5. This evidence concerns the gene FASN and metabolic syndrome.